MicroPort NeuroScientific (HKSE:02172) ROCE % : 19.51% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroScientific ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MicroPort NeuroScientific's annualized ROCE % for the quarter that ended in Jun. 2024 was 19.51%.

MicroPort NeuroScientific ROCE % Historical Data

The historical data trend for MicroPort NeuroScientific's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroScientific ROCE % Chart

MicroPort NeuroScientific Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

12.93

8.40

6.66

9.98

17.26

MicroPort NeuroScientific Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial					13.33	8.62	11.35	19.51	14.80

MicroPort NeuroScientific ROCE % Calculation

MicroPort NeuroScientific's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	181.032	/	( ( (2029.071 - 272.255)	+	(2144.508 - 272.623) )	/ 2 )
	=	181.032	/	( (1756.816	+	1871.885)	/ 2 )
	=	181.032	/	1814.3505
	=	9.98 %

MicroPort NeuroScientific's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	370.89	/	( ( (2144.508 - 272.623)	+	(2239.123 - 308.904) )	/ 2 )
	=	370.89	/	( ( 1871.885	+	1930.219 )	/ 2 )
	=	370.89	/	1901.052
	=	19.51 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

MicroPort NeuroScientific (HKSE:02172) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MicroPort NeuroScientific ROCE % Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroScientific's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort NeuroScientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroScientific Corp (HKSE:02172) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN

Website

https://www.medneurotech.com

MicroPort NeuroScientific Corp formerly MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.

Executives

Microport Scientific Corporation
Hu Yibin
Biolink Biomedical Ltd.	2201 Interest of corporation controlled by you
Blossom Vision Limited	2201 Interest of corporation controlled by you
Lion Fish Limited	2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited	2301 Trustee
Thriving Hope Limited	2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership	2201 Interest of corporation controlled by you
Biolink Limited	2101 Beneficial owner
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroScientific Headlines

No Headlines